Aptose Biosciences Return On Asset vs. Shares Owned By Insiders

APS Stock  CAD 0.25  0.01  3.85%   
Based on Aptose Biosciences' profitability indicators, Aptose Biosciences' profitability may be sliding down. It has an above-average odds of reporting lower numbers next quarter. Profitability indicators assess Aptose Biosciences' ability to earn profits and add value for shareholders. At this time, Aptose Biosciences' EV To Sales is very stable compared to the past year. As of the 27th of November 2024, Sales General And Administrative To Revenue is likely to grow to 47.11, while Price To Sales Ratio is likely to drop 12.36. At this time, Aptose Biosciences' Total Other Income Expense Net is very stable compared to the past year. As of the 27th of November 2024, Net Interest Income is likely to grow to about 1.2 M, while Accumulated Other Comprehensive Income is likely to drop (4.5 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin1.041.1
Notably Down
Slightly volatile
For Aptose Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aptose Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aptose Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aptose Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aptose Biosciences over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Aptose Biosciences Shares Owned By Insiders vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Aptose Biosciences's current stock value. Our valuation model uses many indicators to compare Aptose Biosciences value to that of its competitors to determine the firm's financial worth.
Aptose Biosciences is rated third in return on asset category among its peers. It is rated second in shares owned by insiders category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aptose Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aptose Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Aptose Shares Owned By Insiders vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Aptose Biosciences

Return On Asset

 = 

Net Income

Total Assets

 = 
-1.36
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Aptose Biosciences

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
15.87 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Aptose Shares Owned By Insiders Comparison

Aptose Biosciences is currently under evaluation in shares owned by insiders category among its peers.

Aptose Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Aptose Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aptose Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Aptose Biosciences' change in net profit over the period of time. It can combine multiple indicators of Aptose Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-4.3 M-4.5 M
Operating Income-52.4 M-49.7 M
Net Loss-51.2 M-48.6 M
Income Tax Expense-693 K-658.4 K
Income Before Tax-51.2 M-48.6 M
Total Other Income Expense Net1.1 M1.2 M
Net Loss-51.2 M-48.6 M
Net Loss-37.6 M-39.5 M
Interest Income1.2 M577.1 K
Net Interest Income1.2 M1.2 M
Change To Netincome23.5 M24.7 M
Net Loss(7.58)(7.96)
Income Quality 0.87  0.62 
Net Income Per E B T 0.88  0.79 

Aptose Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Aptose Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aptose Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aptose Biosciences' important profitability drivers and their relationship over time.

Use Aptose Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.

Aptose Biosciences Pair Trading

Aptose Biosciences Pair Trading Analysis

The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Aptose Biosciences position

In addition to having Aptose Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Construction Materials Thematic Idea Now

Construction Materials
Construction Materials Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Construction Materials theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Construction Materials Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Aptose Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptose Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptose Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptose Biosciences Stock:
Check out Trending Equities.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
To fully project Aptose Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aptose Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aptose Biosciences' income statement, its balance sheet, and the statement of cash flows.
Potential Aptose Biosciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Aptose Biosciences investors may work on each financial statement separately, they are all related. The changes in Aptose Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aptose Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.